Skip to main content

Uterine Fibroid Industry Therapeutics, Strategic Assessment, Diagnosis and Focus On Key Drivers


United States Uterine Fibroid Industry Drivers:


United States Uterine Fibroid Industry – Overview

The United States Uterine Fibroid Industry is showing the significant growth; mainly due to change in lifestyle mainly dietary pattern, growing number of hysterectomy surgeries. Additionally rising in aging population also leads the Uterine Fibroid Industry with in this region. According to U.S. Department of Health and Human Services, study found that before 50s 70% of white and 80% of African Americans are diagnosed with fibroids. Also more than 200,000 hysterectomies are performed each year for uterine fibroids. Hysterectomies is the surgery that is used to remove the uterus, if the condition is painful.

 AstraZeneca (U.K), Cook Medical Inc. (U.S.), Boston Scientific Corporation (U.S.), GE Healthcare (U.K), AbbVie Inc. (U.S.), Hologic (U.S.), CooperSurgical Inc. (U.S.), C. R. Bard, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), and Bayer AG (Germany) are some of the leading players at the cutting edge of the competition in the market of Uterine Fibroid.

 Uterine fibroids Industry are the noncancerous growths of the uterus, which mostly appear during childbearing years. It is the abnormal growth of that gets developed inside or on the wall of a woman’s uterus. Uterine fibroids is also known as myomas or leiomyomas. The symptom of uterine fibroids are frequent urination, constipation, backache, heavy menstrual bleeding, pelvic pressure, or menstrual periods lasting more than a week. The women with mild symptoms may go for medical treatments such as hormonal drugs, gonadotropin agonists, progestin and oral contraceptives. Women with moderate to severe symptoms may need surgery to treat uterine fibroids. According to the U.S. Department of Health and Human Services office on Women Health, about 20% to 80% of women develop fibroids by the age of 50 and nearly 30% will get them at the age of 35. Uterine fibroids are most common in women in their 40s and early 50s.

United States Uterine Fibroid Industry   - Regional Analysis
The market of Uterine Fibroid devices is much higher in the United States region, owing to its high prevalence in African- American race, change in lifestyle. According to one large cohort study of NIS on African-American women in Maryland, uterine fibroids was the cause of 65.4% of total 53,000 women undergoing hysterectomy.
Moreover, most of the major market players belong from this region, thus they introduce the advance technology firstly in the United States in comparison to others region.

Inquire for Sample Research Report https://www.marketresearchfuture.com/sample_request/2394  
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Labels:

Comments

Post a Comment

Popular posts from this blog

hyperpigmentation disorders treatment Overview

hyperpigmentation disorders treatment Analysis Hyperpigmentation disorder are harmless skin condition caused by darkened skin patches. Rising demand for outpatient dermabrasion procedures, increasing adoption of lasers and growing cosmetics expenditure are expected to drive the growth of the market. Additionally, rising R&D spending followed aggressive strategies by the key market players is generating awareness for the disease boosting the market to grow. The global hyperpigmentation disorders treatment Market was anticipated to held a market value of USD 3,915 million in the year 2017 and is expected to grow at a CAGR of 7.1% during the forecast period. Browse Complete Premium Research Report Enabled with Respective Tables and Figures at  https://www.marketresearchfuture.com/reports/hyperpigmentation-disorders-treatment-market-7462 Segmentation of The global h yperpigmentation disorders treatment market Segments  has been segmented based on treatment type, dise...
Post a Comment
Read more

Laminated Glass Market Rising Trends, Global Opportunity, demand Analysis and Precise Industry Outlook

Laminated Glass Market Research Overview 2021-2026: Laminated Glass Growth Analysis by Key Players, Types, Applications, Countries, and Forecast. This Laminated Glass research report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. The Research study also analyses key emerging trends and their impact on present and future development. The process has significantly miniaturized various tools that creates more opportunities for the Laminated Glass section to penetrate the growth is valued at xx million US$ in 2020 and is expected to reach xx million US$ by the end of 2026, at a growing CAGR of xx%. Inquire for Free Sample Pages before Purchase of this Research Report: https://www.industrydataanalytics.com/reports/global-laminated-glass-market/inquiry?Mode=rohit The Laminated Glass Market Dynamics Majorly Targeted the Restraints Factors, Growth Opportunities and Future Challenges d...
Post a Comment
Read more

Newer Technology in Dupuytren’s contracture Market Treatment and Diagnosis Overview

Dupuytren's contracture is a condition in which there is difficulty in articulating fingers due to formation of tissue knots under the skin. In severe conditions, the fingers become permanently bent in a flexed position. Dupuytren's contracture is typically not painful and generally affects the ring finger followed by the little and middle finger. The exact causes of Dupuytren's contracture are unknown however the risk factors include alcoholism, smoking, thyroid problems, liver disease, diabetes, previous hand trauma, epilepsy, family history etc. The market drivers for Dupuytren’s contracture market are, increase in risk factors rising incomes, growing screening, increasing geriatric population etc. The market restraints are cost of Dupuytren’s contracture surgery, complications and risk of the surgery, invasive nature of treatment, and regression of the disease even after treatment etc. The  global Dupuytren’s contracture market is expected to reach USD 5.5 billion ...
Post a Comment
Read more